VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
Simcere Pharmaceutical (02096.HK) Rises Over 3% on Exclusive Promotion Agreement with PrimeGene Therapeutics
Simcere Pharmaceutical (02096.HK) Rises Over 3% on Exclusive Promotion Agreement with PrimeGene Therapeutics
Jun 10, 2026 13:39 CST Updated 15:18
Share:
Simcere
Innovative Drug Developer
